The Impact of COPD on in-Hospital Outcomes in Patients with Takotsubo Cardiomyopathy

References

• HurstRT, PrasadA, AskewJW, SenguptaPP, TajikAJ. Takotsubo cardiomyopathy: a unique cardiomyopathy with variable ventricular morphology. JACC Cardiovasc Imaging. 2010;3(6):641–649. doi:10.1016/j.jcmg.2010.01.00920541719
   PubMed Web of Science ®Google Scholar
• OnoR, FalcãoLM. Takotsubo cardiomyopathy systematic review: pathophysiologic process, clinical presentation and diagnostic approach to takotsubo cardiomyopathy. Int J Cardiol. 2016;209:196–205. doi:10.1016/j.ijcard.2016.02.01226896623
   PubMed Web of Science ®Google Scholar
• TemplinC, GhadriJR, DiekmannJ, et al. Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Engl J Med. 2015;373(10):929–938. doi:10.1056/NEJMoa140676126332547
   PubMed Web of Science ®Google Scholar
• BietryR, ReyentovichA, KatzSD. Clinical management of takotsubo cardiomyopathy. Heart Fail Clin. 2013;9(2). doi:10.1016/j.hfc.2012.12.003
   PubMed Web of Science ®Google Scholar
• PrasadA, LermanA, RihalCS. Apical ballooning syndrome (tako-tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J. 2008;155(3):408–417. doi:10.1016/j.ahj.2007.11.00818294473
   PubMed Web of Science ®Google Scholar
• MurugiahK, WangY, DesaiNR, et al. Trends in short- and long-term outcomes for takotsubo cardiomyopathy among medicare fee-for-service beneficiaries, 2007 to 2012. JACC Heart Fail. 2016;4(3):197–205. doi:10.1016/j.jchf.2015.09.01326746377
   PubMed Web of Science ®Google Scholar
• PellicciaF, PasceriV, PattiG, et al. Long-term prognosis and outcome predictors in takotsubo syndrome: a systematic review and meta-regression study. JACC Heart Fail. 2019;7(2):143–154. doi:10.1016/j.jchf.2018.10.00930611720
   PubMed Web of Science ®Google Scholar
• AgdamagAC, PatelH, ChandraS, et al. Sex differences in takotsubo syndrome: a narrative review. J Womens Health (Larchmt). 2020;29(8):1122–1130.31549884
   PubMed Web of Science ®Google Scholar
• ZaghlolR, DeyAK, DesaleS, BaracA. Racial differences in takotsubo cardiomyopathy outcomes in a large nationwide sample. ESC Heart Fail. 2016;7(3):1056–1063. doi:10.1002/ehf2.12664
   Web of Science ®Google Scholar
• Zalewska-AdamiecM, MalyszkoJ, Bachórzewska-GajewskaH, Tomaszuk-KazberukA, DobrzyckiSJ. Takotsubo syndrome – fatal prognosis of patients with low body mass index in 5-year follow-up. Arch Med Sci. 2020;16(2):282–288.32190137
   PubMed Web of Science ®Google Scholar
• StiermaierT, SantoroF, El-BattrawyI, et al. Prevalence and prognostic impact of diabetes in takotsubo syndrome: insights from the international, multicenter GEIST registry. Diabetes Care. 2018;41(5):1084–1088. doi:10.2337/dc17-260929449312
   PubMed Web of Science ®Google Scholar
• KimH, SenecalC, LewisB, et al. Natural history and predictors of mortality of patients with takotsubo syndrome. Int J Cardiol. 2018;267:22–27. doi:10.1016/j.ijcard.2018.04.13929957259
   PubMed Web of Science ®Google Scholar
• BentoD, AzevedoO, SantosR, et al. Short- and medium-term prognosis of takotsubo syndrome in a Portuguese population. Rev Port Cardiol. 2019;38(5):349–357. doi:10.1016/j.repc.2018.07.01031221486
   PubMedGoogle Scholar
• YassinAS, AdegbalaO, SubahiA, et al. Clinical impact of advanced chronic kidney disease on outcomes and in-hospital complications of takotsubo syndrome (broken-heart-syndrome): propensity-matched national study. Int J Cardiol. 2019;277:16–19. doi:10.1016/j.ijcard.2018.09.09830293663
   PubMed Web of Science ®Google Scholar
• PauwelsRA, RabeKF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004;364(9434):613–620. doi:10.1016/S0140-6736(04)16855-415313363
   PubMed Web of Science ®Google Scholar
• HalbertRJ, IsonakaS, GeorgeD, IqbalA. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest. 2003;123(5):1684–1692. doi:10.1378/chest.123.5.168412740290
   PubMed Web of Science ®Google Scholar
• TornvallP, CollsteO, EhrenborgE, Järnbert-PettersonH, Case-ControlA. Study of risk markers and mortality in takotsubo stress cardiomyopathy. J Am Coll Cardiol. 2016;67(16):1931–1936.27102508
   PubMed Web of Science ®Google Scholar
• Zalewska-AdamiecM, Bachorzewska-GajewskaH, Tomaszuk-KazberukA, et al. Takotsubo cardiomyopathy: serious early complications and two-year mortality – a 101 case study. Neth Heart J. 2016;24(9):511–519. doi:10.1007/s12471-016-0857-z27401602
   PubMed Web of Science ®Google Scholar
• HerttingK, KrauseK, HärleT, BoczorS, ReimersJ, KuckK-H. Transient left ventricular apical ballooning in a community hospital in Germany. Int J Cardiol. 2006;112(3):282–288. doi:10.1016/j.ijcard.2005.09.00616325287
   PubMed Web of Science ®Google Scholar
• El-SayedAM, BrinjikjiW, SalkaS. Demographic and co-morbid predictors of stress (takotsubo) cardiomyopathy. Am J Cardiol. 2012;110(9):1368–1372. doi:10.1016/j.amjcard.2012.06.04122819424
   PubMed Web of Science ®Google Scholar
• RajwaniA, AdamZ, HallJA. Bronchogenic stress cardiomyopathy: a case series. Cardiology. 2015;130(2):106–111. doi:10.1159/00036929625612607
   PubMed Web of Science ®Google Scholar
• WhiteJM, StewartRAH. Troponin elevation during exacerbations of chronic obstructive airways disease due to stress cardiomyopathy. Int J Cardiol. 2012;160(3):206–207. doi:10.1016/j.ijcard.2012.06.04922762782
   PubMed Web of Science ®Google Scholar
• PetersS. Association between chronic obstructive pulmonary disease and tako tsubo cardiomyopathy – a case report. Int J Cardiol. 2014;176(3):e101.25127963
   PubMed Web of Science ®Google Scholar
• HCUP Nationwide Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP). Agency for healthcare research and quality. Rockville, MD. Available from: https://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed 727, 2020.
   Google Scholar
• KheraR, KrumholzHM. With great power comes great responsibility: big data research from the national inpatient sample. Circ Cardiovasc Qual Outcomes. 2017;10(7):e003846. doi:10.1161/CIRCOUTCOMES.117.00384628705865
   PubMed Web of Science ®Google Scholar
• BenedettoU, HeadSJ, AngeliniGD, BlackstoneEH. Statistical primer: propensity score matching and its alternatives. Eur J Cardiothorac Surg. 2018;53(6):1112–1117. doi:10.1093/ejcts/ezy16729684154
   PubMed Web of Science ®Google Scholar
• StuartEA, LeeBK, LeacyFP. Prognostic score-based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research. J Clin Epidemiol. 2013;66(8Suppl). doi:10.1016/j.jclinepi.2013.01.013
   PubMed Web of Science ®Google Scholar
• WittsteinIS, ThiemannDR, LimaJAC, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352(6):539–548. doi:10.1056/NEJMoa04304615703419
   PubMed Web of Science ®Google Scholar
• AnandIS, ChandrashekharY, FerrariR, et al. Pathogenesis of congestive state in chronic obstructive pulmonary disease. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones during edema and after recovery. Circulation. 1992;86(1):12–21. doi:10.1161/01.CIR.86.1.121617764
   PubMed Web of Science ®Google Scholar
• KellerR, LohmannFW, SchürenKP. Catecholamines in chronic respiratory insufficiency. Respiration. 1971;28(3):273–279. doi:10.1159/0001928434938296
   PubMed Web of Science ®Google Scholar
• MatsuuraT, UenoM, IwanagaY, MiyazakiS. Importance of sympathetic nervous system activity during left ventricular functional recovery and its association with in-hospital complications in takotsubo syndrome. Heart Vessels. 2019;34(8):1317–1324. doi:10.1007/s00380-019-01359-430796565
   PubMed Web of Science ®Google Scholar
• CiutacAM, DawsonD. The role of inflammation in stress cardiomyopathy. Trends Cardiovasc Med. 2020. doi:10.1016/j.tcm.2020.03.005
   PubMed Web of Science ®Google Scholar
• SantoroF, TarantinoN, FerrarettiA, et al. Serum interleukin 6 and 10 levels in takotsubo cardiomyopathy: increased admission levels may predict adverse events at follow-up. Atherosclerosis. 2016;254:28–34. doi:10.1016/j.atherosclerosis.2016.09.01227680775
   PubMed Web of Science ®Google Scholar
• YasudaN, GotohK, MinatoguchiS, et al. An increase of soluble fas, an inhibitor of apoptosis, associated with progression of COPD. Respir Med. 1998;92(8):993–999. doi:10.1016/S0954-6111(98)90343-29893764
   PubMed Web of Science ®Google Scholar
• MadiasJE. ‘Bronchogenic stress cardiomyopathy’, a subset of takotsubo syndrome. Cardiology. 2015;131(3):160. doi:10.1159/00037657125967347
   PubMed Web of Science ®Google Scholar
• KyumaM, TsuchihashiK, ShinshiY, et al. Effect of intravenous propranolol on left ventricular apical ballooning without coronary artery stenosis (ampulla cardiomyopathy): three cases. Circ J. 2002;66(12):1181–1184. doi:10.1253/circj.66.118112499630
   PubMed Web of Science ®Google Scholar
• IsogaiT, MatsuiH, TanakaH, FushimiK, YasunagaH. Early β-blocker use and in-hospital mortality in patients with takotsubo cardiomyopathy. Heart. 2016;102(13):1029–1035. doi:10.1136/heartjnl-2015-30871226879240
   PubMed Web of Science ®Google Scholar